We advised the initial purchasers on the offering

Davis Polk advised the representative of the several initial purchasers in connection with a Rule 144A / Regulation S offering by H.B. Fuller Company of $850 million aggregate principal amount of its 7.625% notes due 2034. The notes were issued as part of the financing for H.B. Fuller’s pending acquisition of Advanced Medical Solutions Group plc.

Founded in 1887, H.B. Fuller is the largest pureplay adhesives company in the world. Its functional coatings, adhesives and sealants enhance the quality, safety and performance of products people use every day. H.B. Fuller’s more than 7,100 team members collaborate with customers across more than 30 market segments in 150 countries to develop highly specified solutions for their end markets.

The Davis Polk capital markets team included partner Hillary A. Coleman and associates Soo Kyung Chae and Madeline Y. Owens. Partner Patrick E. Sigmon and associate Omar Hersi provided tax advice. The intellectual property team included partner Matthew J. Bacal. Counsel Will Schisa and associate Josh Slifka provided sanctions advice. Members of the Davis Polk team are based in the New York and Washington DC offices.

Copy link to share post